GlassScriptPhysician profile
Nancy A Bosse
NPI 1952607558
$926.08
in general payments reported to CMS, 2019-2025
16 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.80 · 2022: $180 · 2023: $232 · 2024: $58.82 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $164.64 | 2021-2025 | Mounjaro, Trulicity, Zepbound |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $124.92 | 2025 | Caplyta |
| Abbvie INC. | $107.60 | 2022-2023 | |
| Mylan Specialty L.P. | $88.42 | 2022-2023 | Yupelri |
| Pfizer INC. | $58.90 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.23 | 2025 | Eohilia |
| Melinta Therapeutics, LLC | $58.15 | 2023-2025 | Kimyrsa, Rezzayo, Orbactiv |
| Abbott Laboratories | $52.93 | 2023-2025 | Infinity, Freestyle Libre 2 |
| Grt US Holding, INC. | $52.15 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $43.04 | 2023 | Breztri |
| Astellas Pharma US INC | $29.34 | 2023-2025 | Veozah |
| Amarin Pharma, INC. | $23.64 | 2021 | |
| Dexcom, INC. | $18.25 | 2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $16.37 | 2025 | |
| Verona Pharma, INC. | $15.46 | 2025 | Ohtuvayre |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $14.04 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Bosse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.